株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のコンパニオンアニマル医療市場:製品別(ワクチン、寄生虫駆除剤、抗炎症薬、医療用食品添加物、その他の医薬品)、診断技術別、動物別(犬、猫、馬)、地域別 - 動向および予測

Companion Animal Health Market By Products (Vaccines, Paraciticides, Anti-Infectives, Medicinal Feed Additives, And Other Pharmaceuticals), By Diagnostic Technologies, By Animals Type (Dogs, Cats And Horses), By Geography-Trends And Forecast (2016-2021)

発行 Mordor Intelligence LLP 商品コード 319394
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
世界のコンパニオンアニマル医療市場:製品別(ワクチン、寄生虫駆除剤、抗炎症薬、医療用食品添加物、その他の医薬品)、診断技術別、動物別(犬、猫、馬)、地域別 - 動向および予測 Companion Animal Health Market By Products (Vaccines, Paraciticides, Anti-Infectives, Medicinal Feed Additives, And Other Pharmaceuticals), By Diagnostic Technologies, By Animals Type (Dogs, Cats And Horses), By Geography-Trends And Forecast (2016-2021)
出版日: 2016年01月01日 ページ情報: 英文
概要

世界のコンパニオンアニマル医療市場は、2013年に85億米ドル規模となりました。同市場は今後もCAGR7.86%で成長しつづけ、2019年には133億7,000万米ドルに達するとみられています。

当レポートでは、世界のコンパニオンアニマル医療市場の現状と将来予測、セグメント別、地域別動向とともに、主要な参入企業の競合環境とプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品
  • 動物医療と人間医療

第3章 市場動向

  • 市場促進因子
    • ペットオーナーシップ
    • 栄養の改善
    • 消費者が食品の安全性への注意を高めている
    • 飼料の増産
    • 動物原性感染病および食物経由の疾患
  • 市場阻害因子
    • 耕作地と水の危機
    • 耕作地の競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 市場セグメンテーション

  • 製品別
    • 寄生虫駆除剤
    • 抗炎症薬
    • 医療用食品添加物
    • その他の医薬品
    • ワクチン
  • コンパニオンアニマル

第5章 世界のコンパニオンアニマル診断薬市場

  • 酵素結合免疫吸着検査法
  • 即時免疫移動
  • 寒天ゲル免疫核酸法

第6章 世界のコンパニオンアニマル遺伝学市場

第7章 地域別市場セグメンテーション

  • 北米
  • 欧州
  • アジア太平洋地域

第8章 競合環境

  • 市場における主要企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、パートナーシップ
  • その他

第9章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第10章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The global market for companion animal healthcare is valued at USD 9.8 billion in 2015 and it is projected to reach USD 14.43 billion by 2020 at a CAGR of 7.86% during the forecast period 2015-2020.

Veterinary healthcare deals with food safety; prevention, diagnosis and treatment of diseases, disorders or any injuries in animals and consistently monitoring the health of animals. In United States alone, Americans spent more than USD 53 billion on food, pet supplies, over-the-counter and prescription medications, veterinary care, live animal purchases, and other pet-related services.

The end-user market is segmented into veterinary hospitals, clinics and reference laboratories. Veterinary Hospitals and clinics are the major sub segments contributing to the economic growth of this market. Pet owners/lovers utilize the animal health services provided by physicians or care providers.

Rising incidence of diseases (food-borne and zoonotic) in animals which consequently transfer to human beings and awareness for animal health, are the major driving factors for the market. Another factor that drives the market is continuous innovations and technological advances in development of animal health drugs. On other hand, Scarcity of arable land and water, increased competition for cultivated land and Cost effective production are constraining the growth of this market.

The companion animal health market is segmented based on Product type, Animal Diagnostics and Animal Genetics. Animal products segment includes Vaccines, Parasiticides, Anti-infectives, Feed additives and Pharmaceuticals. Feed additives is further segmented into Nutritional Feed Additives and Medicinal Feed Additives. Animal diagnostics segment includes Enzyme Linked Immuno Sorbent Assay (ELISA), Rapid Immuno Migration (RIM) and Agar Gel Immuno Diffusion (AGID). The genetics segment includes sub-segments like HD 50K for Angus, CLARIFIDE® for Dairy, Sheep 50K and CLARIFIDE® for Nelore.

Based on geography, the market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, and Brazil will be the major contributors in the market.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global companion animal health market

Key Deliverables in the Study

  • 1. Market analysis for the Global Companion Animal healthcare Market, with region specific assessments and competition analysis on global and regional scales
  • 2. Market definition along with the identification of key drivers and restraints
  • 3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
  • 4. Extensively researched competitive landscape section with profiles of major companies along with their market shares
  • 5. Identification and analysis of the macro and micro factors that affect the Global Companion Animal healthcare Market on both global and regional scales
  • 6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
  • 7. A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
  • 8. Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Table of Contents

  • Introduction
  • Study Deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast Period Years
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions
  • Executive Summary
  • Key Inferences
  • Market Overview and Industry Trends
  • Current Market Scenario
  • Applications of Companion Animal Healthcare
  • Technology Overview
  • New Developments
  • Industry Value-Chain Analysis
  • Product Life-Cycle Analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat of New Entrants
  • Threat of Substitute Products and Services
  • Competitive Rivalry within the Industry
  • Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
  • Market Drivers
  • Rising incidence of diseases (food-borne and zoonotic) in animals
  • Awareness for animal health
  • Continuous innovations and technological advances in development of animal health drug
  • Market Restraints
  • Increased competition for cultivated land
  • Cost effective production
  • Scarcity of arable land and water
  • Key Challenges
  • Current Opportunities in the Market
  • Market Segmentation
  • By Product type
  • Vaccines
  • Parasiticides
  • Anti-infectives
  • Feed additives
  • Nutritional Feed Additives
  • Medicinal Feed Additives
  • Pharmaceuticals
  • By Animal diagnostics
  • Enzyme Linked Immuno Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno Diffusion (AGID)
  • By End-User
  • Veterinary Hospitals
  • Clinics
  • Reference laboratories
  • By Geography
  • North America
  • Introduction
  • US
  • Canada
  • Mexico
  • Europe
  • Introduction
  • France
  • UK
  • Germany
  • Italy
  • Spain
  • Asia-Pacific
  • Introduction
  • India
  • China
  • Japan
  • Australia & New Zealand
  • South Korea
  • Middle-East and North Africa (MENA)
  • Introduction
  • GCC
  • Egypt
  • Algeria
  • South America
  • Introduction
  • Brazil
  • Argentina
  • Others
  • Competitive Landscape
  • Merger and Acquisition Analysis
  • New Product Launches
  • Agreements, Collaborations & Partnerships

    9. Company Profiles

  • Pfizer
  • Merck
  • Sanofi-Aventis
  • Bayer HealthCare
  • Virbac
  • Novartis
  • Boehringer Ingelheim
  • Heska Corporation
  • Bioniche Animal Health Canada, Inc.
  • Ceva
  • Analyst Outlook for Investment Opportunities
  • Future Outlook of the Market
Back to Top